This is the default blog title

This is the default blog subtitle.

Reminder: Upcoming UK (GB and NI) expiry dates

Reminder: Upcoming UK (GB and NI) expiry dates

UK Establishment
All UK Product Authorisation Holders must be established (a person, company or authorised representative) in the UK (Great Britain and/or Northern Ireland) by the 31 December 2021. If not, HSE will cancel their product authorisation(s). This means your product(s) cannot be supplied or used in the UK.

Biocidal products must be phased off the GB market
The following AS/PT combination is due to expire under the GB BPR on the following date: Aluminium phosphide releasing phosphine (CAS 20859-73-8) in PT 18 by 31 January 2022. Once the approval expires, the active substance can no longer be used in biocidal products of the relevant PT in Great Britain.

Apply for product authorisation by the deadlines to keep your products on the North Ireland and the EU market

  • Formaldehyde (CAS 50-00-0) in PTs 2 and 3 by 1 February 2022
  • Icaridine (CAS 119515-38-7 EC 423-210-8) in PT 19 by 1 February 2022
  • Alkyl (C12-16) dimethylbenzyl ammonium chloride (CAS 68424-85-1) in PT 3 & 4 by 1 November 2022
  • Didecyldimethylammonium chloride (CAS 7173-51-5) in PT 3 & 4 by 1 November 2022

GB Review programme
If you want to take the opportunity to take over the role of participant in the GB Review Programme for certain AS/PT combination, this application should be done by 12 November 2022.

GB Article 95 list
Companies that were already on the EU list on 31 December 2020 are included in the GB list. To remain on the list, an application must be submitted to HSE by 31 December 2022.

GB active substance expiry dates postponed
For reasons beyond the control of the applicants, the approvals of the following AS/PT combinations were likely to expire before a decision could be taken on their renewal under the GB BPR. To allow sufficient time for the renewal evaluation to be completed, a decision has been taken to postpone the expiry of the approvals until the following dates:

  • Creosote (CAS 8001-58-9) in PT8 by 24 July 2023
  • Trimagnesium diphosphide (CAS 12057-74-8) in PT18 by 31 January 2025
  • Dinotefuran (CAS 165252-70-0) in PT18 by 31 May 2025
  • Indoxacarb (CAS n/a) in PT18 by 30 June 2025
  • Dazomet (CAS 533-74-4) in PT8 by 31 July 2025
  • DEET (CAS 134-62-3) in PT19 by 31 July 2025
  • Tebuconazole (CAS 107534-96-3) in PT8 by 30 September 2025
  • Spinosad (CAS 168316-95-8) in PT18 by 31 October 2025

Add comment